Login to Your Account

Prospects brightening for EU EPP patients as Scenesse rollout looms

By Nuala Moran
Staff Writer

Friday, June 5, 2015

Summer has been slow to arrive in Europe this year, a blessing for patients with erythropoietic protoporphyria, an extreme sensitivity to sunlight, who have been awaiting the market rollout of the first approved treatment, Scenesse.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription